Intas Pharma is likely to file Draft Red Herring Prospectus (DRHP) with Securities and Exchange Board of India (Sebi), in the next two weeks. It has decided to revive its IPO plan.
first published: May 20, 2013 07:30 pm
A collection of the most-viewed Moneycontrol videos.

Live: Davos 2026 Day 4 Highlights | AI, TRUMP, INDIA INSIGHTS & Global CEO Voices

Live: Nifty cools off from day's high but snaps 3-day losing streak | Closing Bell

Live: Will Nifty break 3-day losing streak as Trump walks back on EU tariffs? | Opening Bell

Why India needs to rethink protectionism and bring in capital market reforms - Jahangir Aziz
You are already a Moneycontrol Pro user.

